Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Breast Adenocarcinoma|Inflammatory Breast Carcinoma
Interventions: BIOLOGICAL: pertuzumab|BIOLOGICAL: trastuzumab|DRUG: paclitaxel albumin-stabilized nanoparticle formulation|OTHER: laboratory biomarker analysis
Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)